1,720,966 research outputs found
Suppression of IL-23-Mediated Psoriasis-like Inflammation by Regulatory B cells
No full text博士論文 要旨Abstract/本文Full 以下に掲載：Scientific Reports 11(1) pp.2106- 2021. Springer. 共著者：Kie Mizumaki, Motoki Horii, Miyu Kano, Akito Komuro, Takashi Matsushit
Cytokine-producing B-cell balance associates with skin fibrosis in patients with systemic sclerosis
No full text博士論文 要旨Abstract/本文Full 以下に掲載：The Journal of Dermatology 49(10) pp.1012-1019 2022. 日本皮膚科学会. 共著者：Motoki Horii, Natsumi Fushida, Tomoyuki Ikeda, Kyousuke Oishi, Yasuhito Hamaguchi, Yuichi Ikawa, Akito Komuro, Takashi Matsushit
Immunomodulating role of the JAKs inhibitor tofacitinib in a mouse model of bleomycin-induced scleroderma
Get PDF金沢大学博士(医学）博士論文 要旨Abstract/本文Full 以下に掲載：Journal of Dermatological Science 101(3) pp.174-184 2021. Elsevier. 共著者：Wah Wah Aung, Chenyang Wang, Jia Xibei, Motoki Horii, Kie Mizumaki, Miyu Kano, Ai Okamura, Tadahiro Kobayashi, Takashi Matsushitadoctoral thesi
Suppression of IL-23-Mediated Psoriasis-like Inflammation by Regulatory B cells
Get PDF金沢大学博士(医学）博士論文 要旨Abstract/本文Full 以下に掲載：Scientific Reports 11(1) pp.2106- 2021. Springer. 共著者：Kie Mizumaki, Motoki Horii, Miyu Kano, Akito Komuro, Takashi Matsushitadoctoral thesi
Cytokine-producing B-cell balance associates with skin fibrosis in patients with systemic sclerosis
Get PDF金沢大学博士(医学）博士論文 要旨Abstract/本文Full 以下に掲載：The Journal of Dermatology 49(10) pp.1012-1019 2022. 日本皮膚科学会. 共著者：Motoki Horii, Natsumi Fushida, Tomoyuki Ikeda, Kyousuke Oishi, Yasuhito Hamaguchi, Yuichi Ikawa, Akito Komuro, Takashi Matsushitadoctoral thesi
MUSASHI-2 confers resistance to third-generation EGFR-tyrosine kinase inhibitor osimertinib in lung adenocarcinoma
No full text博士論文 要旨Abstract/本文Full 以下に掲載：Cancer Science 112(9) pp.3810-3821 2021. Wiley-Blackwellon behalf of theJapanese Cancer Association. 共著者：Reheman Yiming, Yasuto Takeuchi, Tatsunori Nishimura, Mengjiao Li, Yuming Wang, Makiko Meguro-Horike, Takashi Kohno, Shin-ichi Horike, Asuka Nakata, Noriko GotohKie Mizumaki, Motoki Horii, Miyu Kano, Akito Komuro, Takashi Matsushit
Immunomodulating role of the JAKs inhibitor tofacitinib in a mouse model of bleomycin-induced scleroderma
No full text博士論文 要旨Abstract/本文Full 以下に掲載：Journal of Dermatological Science 101(3) pp.174-184 2021. Elsevier. 共著者：Wah Wah Aung, Chenyang Wang, Jia Xibei, Motoki Horii, Kie Mizumaki, Miyu Kano, Ai Okamura, Tadahiro Kobayashi, Takashi Matsushit
MUSASHI-2 confers resistance to third-generation EGFR-tyrosine kinase inhibitor osimertinib in lung adenocarcinoma
Get PDF金沢大学博士(医学）博士論文 要旨Abstract/本文Full 以下に掲載：Cancer Science 112(9) pp.3810-3821 2021. Wiley-Blackwell on behalf of the Japanese Cancer Association. 共著者：Reheman Yiming, Yasuto Takeuchi, Tatsunori Nishimura, Mengjiao Li, Yuming Wang, Makiko Meguro-Horike, Takashi Kohno, Shin-ichi Horike, Asuka Nakata, Noriko GotohKie Mizumaki, Motoki Horii, Miyu Kano, Akito Komuro, Takashi Matsushitadoctoral thesi
Going Beyond Counting First Authors in Author Co-citation Analysis
Get PDFThe present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
- …
